Note 11 - Financial Instruments - Summary of Effect of Designated Derivative Financial Instruments on Consolidated Financial Statements (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cost of sales	$ 1,982	$ 2,175
Other expense, net	74	8
Gain (loss) recognized in other comprehensive income	33	32
Net income of reportable segments	209	176
Reclassification out of Accumulated Other Comprehensive Income [Member]
Cost of sales	6	7
Other expense, net		(1)
Net income of reportable segments	6	6
Foreign Exchange Contract [Member]
Cost of sales	$ 33	$ 32